Spine-specific skeletal related events and mortality in non–small cell lung cancer patients: a single-institution analysis

View More View Less
  • 1 Departments of Orthopaedic Surgery and
  • 2 Radiology, Washington University School of Medicine, St. Louis, Missouri
Restricted access

Purchase Now

USD  $45.00

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

The population prevalence of non–small cell lung cancer (NSCLC) continues to increase; however, data are limited regarding the incidence rate of skeletal related events (SREs) (i.e., surgery to the spinal column, radiation to the spinal column, radiofrequency ablation, kyphoplasty/vertebroplasty, spinal cord compression, or pathological vertebral body fractures) and their impact on overall mortality. In this study, the authors sought to estimate the incidence rates of SREs in NSCLC patients and to quantify their impact on overall mortality.

METHODS

This was a single-institution retrospective study of patients diagnosed with NSCLC between 2002 and 2014. The incidence rates for bone metastasis and subsequent SREs (per 1000 person-years) by time since lung cancer diagnosis were calculated and analyses were stratified separately for each histological type. Incidence rates for mortality at 1, 2, and 3 years from diagnosis stratified by the presence of SREs were also calculated. Kaplan-Meier survival curves were constructed to describe crude survival ratios in patients with spine metastasis and SREs and those with spine metastasis but without SREs. These curves were used to estimate the 1- and 2-year survival rates for each cohort.

RESULTS

We identified 320 patients with incident NSCLC (median follow-up 9.5 months). The mean ± SD age was 60.65 ± 11.26 years; 94.48% of patients were smokers and 60.12% had a family history of cancer. The majority of first-time SREs were pathological vertebral body compression fractures (77.00%), followed by radiation (35%), surgery (14%), and spinal cord compression (13.04%). Mortality rates were highest in NSCLC patients with spine metastasis who had at least 1 SRE. Stratifying by histological subtype, the incidence rate of mortality in patients with SRE was highest in the large cell cohort, 7.42 per 1000 person-years (95% CI 3.09–17.84 per 1000 person-years); followed by the squamous cell cohort, 2.49 per 1000 person-years (95% CI 1.87–3.32 per 1000 person-years); and lowest in the adenocarcinoma cohort, 1.68 per 1000 person-years (95% CI 1.46–1.94 per 1000 person-years). Surgery for decompression of neural structures and stabilization of the spinal column was required in 6% of patients.

CONCLUSIONS

SREs in NSCLC patients with bone metastasis are associated with an increased incidence rate of mortality.

ABBREVIATIONS NSCLC = non–small cell lung cancer; RFA = radiofrequency ablation; SRE = skeletal related event.

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Owoicho Adogwa: University of Texas Southwestern Medical School, Dallas, TX. owoicho.adogwa@utsouthwestern.edu.

INCLUDE WHEN CITING Published online November 27, 2020; DOI: 10.3171/2020.7.SPINE20829.

O.A. and D.R.R. share first authorship.

Disclosures Dr. Buchowski reports receiving royalties from Globus Medical and K2M/Stryker and support of a non–study-related clinical or research effort overseen by the author from OMeGA.

  • 1

    Bray F, Ferlay J, Soerjomataram I, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394424.

    • Search Google Scholar
    • Export Citation
  • 2

    Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(8)(suppl):15881594.

  • 3

    Cetin K, Christiansen CF, Jacobsen JB, Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. Lung Cancer. 2014;86(2):247254.

    • Search Google Scholar
    • Export Citation
  • 4

    Delea TE, McKiernan J, Brandman J, Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol. 2006;1(6):571576.

    • Search Google Scholar
    • Export Citation
  • 5

    Sun JM, Ahn JS, Lee S, Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. Lung Cancer. 2011;71(1):8993.

    • Search Google Scholar
    • Export Citation
  • 6

    Sathiakumar N, Delzell E, Morrisey MA, Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006. Lung India. 2013;30(1):2026.

    • Search Google Scholar
    • Export Citation
  • 7

    Delea T, Langer C, McKiernan J, The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology. 2004;67(5-6):390396.

    • Search Google Scholar
    • Export Citation
  • 8

    Pockett RD, Castellano D, McEwan P, The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. Eur J Cancer Care (Engl). 2010;19(6):755760.

    • Search Google Scholar
    • Export Citation
  • 9

    Tsuya A, Kurata T, Tamura K, Fukuoka M. Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer. 2007;57(2):229232.

    • Search Google Scholar
    • Export Citation
  • 10

    Sekine I, Nokihara H, Yamamoto N, Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy. Lung Cancer. 2009;65(2):219222.

    • Search Google Scholar
    • Export Citation
  • 11

    da Silva GT, Bergmann A, Thuler LCS. Incidence and risk factors for bone metastasis in non-small cell lung cancer. Asian Pac J Cancer Prev. 2019;20(1):4551.

    • Search Google Scholar
    • Export Citation
  • 12

    Tominaga H, Setoguchi T, Shimada H, Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis. Mol Clin Oncol. 2017;7(5):897902.

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 271 271 42
Full Text Views 22 22 1
PDF Downloads 12 12 1
EPUB Downloads 0 0 0